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Abstract: Their stability and low cost make catanionic vesicles suitable for application as drug
delivery systems. In this work we prepared catanionic vesicles using biocompatible surfactants:
two cationic arginine-based surfactants (the monocatenary Nα-lauroyl-arginine methyl ester—LAM
and the gemini Nα,N$-bis(Nα-lauroylarginine) α, $-propylendiamide—C3(CA)2) and three anionic
amphiphiles (the single chain sodium dodecanoate, sodium myristate, and the double chain 8-SH).
The critical aggregation concentration, colloidal stability, size, and charge density of these systems were
comprehensively studied for the first time. These catanionic vesicles, which form spontaneously after
mixing two aqueous solutions of oppositely charged surfactants, exhibited a monodisperse population
of medium-size aggregates and good stability. The antimicrobial and hemolytic activity of the vesicles
can be modulated by changing the cationic/anionic surfactant ratio. Vesicles with a positive charge
efficiently killed Gram-negative and Gram-positive bacteria as well as yeasts; the antibacterial activity
declined with the decrease of the cationic charge density. The catanionic systems also effectively
eradicated MRSA (Methicillin-resistant Staphylococcus Aureus) and Pseudomonas aeruginosa biofilms.
Interestingly, the incorporation of cholesterol in the catanionic mixtures improved the stability of these
colloidal systems and considerably reduced their cytotoxicity without affecting their antimicrobial
activity. Additionally, these catanionic vesicles showed good DNA affinity. Their antimicrobial
efficiency and low hemolytic activity render these catanionic vesicles very promising candidates for
biomedical applications.
Keywords: catanionic vesicles; amino acids; biocompatible surfactants; antimicrobial activity;
antibiofilm activity; hemolysis; bacterial selectivity
1. Introduction
The versatile vesicular nanosystems have attracted considerable attention due to their promising
therapeutic applications. They may encapsulate polar drugs in their aqueous compartment and
hydrophobic compounds can be incorporated into the hydrocarbon domain [1]. The most widely
studied are liposomes [2], biocompatible and biodegradable spherical aggregates composed of natural
polar lipids, which present no significant cytotoxicity issues. [3–5]. Nevertheless, liposomes also
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have some important drawbacks: (a) their raw materials, usually phospholipids, are costly; (b) their
production can require a high energy input and lengthy preparation methods with multiple steps
(sonication, extrusion, homogenization) [6], (c) these vesicles are typically non-equilibrium structures
with limited colloidal stability [7] and (d) natural lipids can easily undergo chemical degradation
by hydrolysis.
Catanionic vesicles [8], which spontaneously self-assemble without any energy requirements after
the mixing of inexpensive cationic and anionic surfactant solutions [9], have been investigated
as potential alternatives to liposomes. Among their advantages, catanionic vesicles can be
thermodynamically or kinetically stable for long periods of time, they can be prepared using simple
and economic surfactants, and their size, surface density, flexibility, and permeability can be tailored
by adjusting the concentration, cationic/anionic mixing ratio, temperature, and chain length of
the components and the addition of salts or co-solvents [8]. Due to their physicochemical and
biological properties, catanionic vesicles are of special interest for applications in nanotechnology and
biomedicine. [10–14].
In most studies on catanionic mixtures, alkyl ammonium bromide surfactants are chosen as the
positively charged components [15]. Recently, due to their enhanced properties, catanionic mixtures
containing gemini surfactants such as bis-quaternary ammonium salts have also been used. However,
these cationic surfactants are not biodegradable, and their cytotoxicity precludes their use in some
biomedical applications. In this regard, the conjugation of non-toxic molecules is being explored as a
promising approach to produce biocompatible and biodegradable surfactants that can be incorporated
in catanionic mixtures [16–21].
The arginine amino acid is also an excellent raw material to prepare cationic surfactants
with antimicrobial activity. Years ago, our group addressed the synthesis and physico-chemical
characterization of long-chain Nα-acyl arginine methyl ester compounds and arginine-based gemini
surfactants [17]. Nα-acyl arginine methyl esters are cationic surfactants with high biodegradability,
moderate hemolytic activity, and a surface activity comparable to that of conventional long-chain
quaternary ammonium salts. Moreover, these compounds showed good antimicrobial and antifungal
activity, the most active agent being the 12-carbon homologue (LAM, Figure 1). Moreover,
LAM combined with anionic surfactants, formed mixtures containing polydisperse catanionic vesicles
coexisting with other kinds of structures, [22].
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Figure 1. e ical structure of the cationic and anionic surfactants used in this work: (a) LAM
(b) 3(CA)2, (c) Sodium l urate, (d) Sodiu myristate, and (e) 8-SH.
The gemini surfactants consisted of two symmetrical long-chain residues of
C12 (Nα,Nω-bis(Nα-lauroylarginine)α,ω-alkylendiamides [Cn(LA)2 series] and C10
(Nα,Nω-b s(Nα-caproylarginine)α,ω-alkylendiamides [Cn(CA)2 series] linked by amide bonds to an
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α,ω-alkylenediamine spacer chain of varying length (n = 2–10). The arginine-based gemini surfactants
showed critical micellar concentration (cmc) values [17] one or two orders of magnitude lower than
the corresponding monomeric surfactants and were much more efficient in lowering surface tension.
These gemini surfactants also exhibited excellent biodegradation and good antimicrobial activity.
Interestingly, the most active antimicrobial gemini surfactant, C3(CA)2, performed better than LAM,
the most active monocatenary surfactant [17]. Taking into account the biological and physico-chemical
properties of single-chain and arginine-based gemini surfactants, their use in the preparation of
catanionic mixtures may be advantageous for several biomedical applications. Moreover, it has been
reported that the mode of action of cationic amphiphiles against bacteria hampers the development
of antimicrobial resistance, one of the most serious threats to public health [23] that calls for the
development of new antimicrobial systems.
Here we prepared catanionic mixtures simply by mixing cationic arginine-based surfactants
with anionic surfactants (sodium laurate, sodium myristate and 8-SH) (Figure 1). Three different
systems were studied: one composed of two single-chain surfactants, LAM and sodium myristate,
a second prepared by mixing the cationic gemini C3(CA)2 with the single chain sodium laurate,
and a third composed of C3(CA)2 and the double chain 8-SH. Systems containing gemini surfactants
were also prepared with different contents of cholesterol. The critical aggregation concentration as
well as the size and charge density of the resulting aggregates as a function of surfactant mixing
ratio were determined by fluorescence, conductivity, dynamic light scattering, and zeta potential
studies. Antimicrobial and antibiofilm activity of all the catanionic mixtures was tested against four
Gram-positive bacteria, three Gram negative bacteria, and the yeast-like pathogenic fungus Candida
albicans. The antibiofilm activity against two problematic bacteria (MRSA and Pseudomonas aeruginosa)
was determined. The interaction of the catanionic mixtures with human cells was evaluated using
erythrocytes. Additionally, the DNA-binding capacity of these systems was assessed by ethidium
bromide exclusion experiments.
The study had three main aims: first, to prepare catanionic mixtures using green biocompatible
surfactants, second, to design new formulations with high antimicrobial activities and moderate
toxicity and third, to shed light on how the mixing ratio, the number of alkyl chains in the ion pairs and
the nature of polar heads affect the biological and physico-chemical properties of catanionic vesicles.
We expect that the findings described in this work will contribute to the understanding of the biological
activity of catanionic mixtures from amino acid-based surfactants and help to rationalize the design of
new and safe antimicrobial formulations.
2. Materials and Methods
2.1. Materials
All solvents were reagent grade and used without further purification. Deuterated solvents
were purchased from Eurotop (Cambridge, UK). Mueller-Hinton Broth was purchased from Difco
Laboratories (Detroit, MI, USA). Water from a Milli-Q Millipore system (Millipore, Burlington, MA,
USA) was used to prepare aqueous solutions. Sodium dodecanoate and myristate were from Sigma
(San Luis, MO, USA), while the other surfactants used to prepare the catanionic mixtures (LAM,
C3(CA)2 and 8-SH) were prepared in our laboratory following procedures already described [24,25].
Briefly, the gemini surfactant C3(CA)2 was obtained with a purity of 99% by chemical condensation
of the previously protected single Nα-decyl-l-arginine to the propanediamine in presence of an
activating agent. A final deprotection reaction was carried out to obtain the target surfactant. LAM was
synthesized by the condensation of the lauroyl chloride (Sigma, San Luis, MO, USA) to the amino
group of the commercial arginine methyl ester in basic medium (Sigma, San Luis, MO, USA). Sodium
8-hexadecylsulfate (8-SH) was prepared by sulfonation of 8-hexadecanol (Sigma, San Luis, MO,
USA) with chlorosulfonic acid in acetic acid (Sigma, San Luis, MO, USA). The resulting sulfonic acid
was neutralized by sodium bicarbonate (Sigma-aldrich, San Luis, MO, USA). The detailed synthetic
Pharmaceutics 2020, 12, 857 4 of 24
procedure as well as the characterization of pure compounds (checked by high performance liquid
chromatography (HPLC), Mass spectrometry (MS), proton and carbon-13 nuclear magnetic resonance
(1HNMR, 13CNMR), and elemental analysis) are provided elsewhere.
2.2. Preparations of Catanionic Mixtures
Catanionic formulations were prepared by mixing the appropriate amount of aqueous solutions
of pure surfactants (Table 1). As cholesterol is a very hydrophobic lipid not soluble in water,
cholesterol-containing vesicles were prepared using a hydration method. Firstly, solutions of anionic
surfactants, cationic surfactants, and cholesterol (Sigma-aldrich, San Luis, MO, USA) were prepared
in methanol (Honeywell Riedel-de Haën, Seelze, Germany). Then 2 mL of mixtures containing
the corresponding amount of every pure solution were prepared and the solvent was evaporated.
The resulting film was then hydrated with 2 mL of water and sonicated at 50 ◦C for 15 min.
Table 1. Acronyms and composition (molar) of the catanionic mixtures studied in this work.
Catanionic Mixtures
Acronym LAM (%) Sodium Myristate (%) Acronym C3(CA)2 (%) 8SH (%) Acronym C3(CA)2 (%) Sodium Laurate (%)
8.2.LM 80 20 2.8.C3S 20 80 2.8.C3L 20 80
2.8.LM 20 80 5.5.C3S 50 50 5.5.C3L 50 50
8.2.C3S 80 20 8.2.C3L 80 20
Cholesterol Containing Catanionic Mixtures
Acronym Cholesterol (%) C3(CA)2 (%) 8SH (%) Acronym Cholesterol (%) C3(CA)2 (%) Sodium Laurate (%)
2.8.C3S(10%) 10 18 72 2.8.C3L (10%) 10 18 72
2.8.C3S(20%) 20 16 64 2.8.C3L (20%) 20 16 64
5.5.C3S(10%) 10 45 45 5.5.C3L (10%) 10 45 45
5.5.C3S(20%) 20 40 40 5.5.C3L (20%) 20 40 40
8.2.C3S(10%) 10 72 18 8.2.C3L (10%) 10 72 18
8.2.C3S(20%) 20 64 16 8.2.C3L (20%) 20 64 16
2.3. Fluorescence Measurements
A Shidmadzu RF 540 spectrofluorometer (Shimadzu, Kioto, Japan) was used to measure CMC
by fluorescence, using pyrene (Sigma-aldrich, San Luis, MO, USA) as a fluorescence probe at 25 ◦C.
From a stock solution of catanionic mixtures (1 mM) prepared in a pyrene aqueous solution of 10−6 M,
different dilutions were prepared. The fluorescence emission spectra of these dilutions were recorded
from 340 to 450 nm after excitation at 332 nm. The ratio of the first to the third vibrionic peaks (II/IIII)
in the emission spectra of pyrene depends on the environment polarity and can be used to calculate
the cmc or cac.
2.4. Conductivity
Conductivity of surfactant solutions was measured using an Orion Cond Cell 011010A (Thermo
scientific, Waltham, MA, USA) with platinized platinum electrodes in conjunction with a Thermo
Orion 550A with a cell constant of 0.998 cm−1. The cell constant was calibrated with NaCl/KCl
solutions of known conductivities. Samples for conductivity measurements were prepared in Millipore
ultra-pure water. Measurements were made at increasing concentrations to reduce errors from possible
electrode contamination. The conductivity of water was subtracted from the measured conductivity of
each sample.
2.5. NMR Measurements
The 1HNMR spectra were acquired with a Varian 400 mHz (Varian, Palo Alto, CA, USA) using a
simple one-pulse experiment with a spectral width of 10,000 Hz and a pre-acquisition delay of 5 s.
Binary mixtures were prepared in 1 mL of D2O (1 mM for the catanionic mixtures and 5 mM for LAM
and sodium myristate) of at least 99.8% atom D%. The water impurity in the D2O was used as an
internal reference.
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2.6. ς-Potential and Size Distribution Analysis
The ς-potential of the formulations was measured with Laser Doppler electrophoretic mobility
measurements using a Zetasizer 2000 (Malvern Instruments Ltd., Malvern, UK), at 25 ◦C. All analyses
were done in triplicate. The ς-potential values and standard deviations were acquired directly from
the instrument. The size distribution of all formulations was determined by using the dynamic light
scattering technique (DLS). The DLS unit determining vesicle size was a Malvern Zeta Nanosizer
(Malvern, Malvern, UK), working at 632.8 nm and 25 ◦C. The DLS experiment started 5 min after
the sample solutions were placed in the DLS optical system to allow the sample to equilibrate at the
selected temperature. The scattering intensity was measured at a 173◦ angle to the incident beam.
The backscatter detection allows measurements in turbid dispersions, minimizing multiple scattering
effects. Depending on the system turbidity, the unit automatically determines the sample thickness
under investigation and focuses the beam at a given position from the cell walls. At least 10 runs were
performed for each sample. The viscosity value (0.8872 mPa×s) and the refractive index (1.33) of water
were used for all the measurements. The correlation function is used by the system to calculate the
size distribution. The software supplied by the manufacturer (Zetasizer v6.20, Malvern, Malvern, UK)
automatically determines the optimum parameters for the CONTIN73 algorithm for monomodal as
well as multimodal distributions in order to produce a size distribution profile.
2.7. Antimicrobial Activity
Antimicrobial activity was assessed in vitro by determining the minimum inhibitory concentration
(MIC) values using the broth microdilution method [26]. Antimicrobial assays were carried out using
4 Gram positive bacteria, 3 Gram negative bacteria and one fungal strain: methicillin resistant
Staphylococcus aureus ATCC 43300 (MRSA), Bacillus subtilis ATCC 6633, Kocuria rhizophila 9341,
Staphylococcus epidermidis ATCC 12228, Klebsiella pneumoniae ATCC 4532, Pseudomonas aeruginosa
ATCC 27853, Escherichia coli ATCC 8739, Candida albicans ATCC 10231 (American Type Culture
Collection, Manassas, VA, USA). Frozen stocks of bacterial isolates were spread on Muller Hinton agar
plates and incubated overnight at 37 ◦C. Then, a bacterial suspension of 0.5 McFarland turbidity was
prepared in Muller Hinton broth with a final pH of 7.3 ± 0.1 at 25 ◦C. To obtain the inoculum, these
suspensions were diluted 10 times in Muller Hinton broth to give 107 colony forming units (CFU)/mL.
Two-fold dilutions of pure surfactants and their catanionic mixtures in the same broth were prepared
to obtain a final concentration range of 4 to 250 µM in the 96 microtiter plates. 10 µL of nutrient
broth culture of each bacterial strain was then added to achieve a final microorganism density of ca.
5 × 105 CFU/mL. Every assay was performed in triplicate. The lowest concentration of the catanionic
mixtures that inhibits visible growth of every microorganism (after 24 h of incubation at 37 ◦C) was
regarded as the MIC. The minimum bactericidal concentration (MBC) was recorded as the lowest
concentration, killing 99.9% of the bacterial inoculum after 24 h incubation at 37 ◦C. MBC values were
determined by inoculating in nutrient agar plates 100 µL of bacterial suspension from the wells whose
concentrations are ≥ MIC. Plates were incubated at 37 ◦C for 24 h. Each test was repeated at least
three times.
2.8. Antibiofilm Activity
Bacteria were grown overnight in Tryptic-Soy agar at 37 ◦C for 24 h. The bacteria were suspended
in lysogeny broth with glucose (1%) at 1.5 × 108 CFU/mL. For mature biofilm formation, 200 µL of
the diluted bacterial suspension was added to each well in a 96-well microplate and incubated at
37 ◦C for 24 h. The wells were gently rinsed with phosphate buffered saline (PBS) and 200 µL of the
corresponding catanionic formulation was added to each well and incubated again at 37 ◦C for 24 h.
Two-fold product concentration ranges were used (125–2.5 µM). After treatment, the biofilms were
fixed with 100 µL methanol for 15 min. After the plates were air dried, the biofilms were stained with
50 µL of 0.1 of % crystal violet for 25 min. The plates were rinsed with water and 150 µL of 96% ethanol
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was added to all 96 wells to dissolve the remaining crystal violet stained biofilm. The O.D value
was recorded at 570/630 nm. Controls were performed with non-catanionic formulations (untreated).
Each assay was carried out four times and the results were averaged.
2.9. Hemolysis Assay
For the preparation of erythrocyte suspensions, fresh blood was taken from rabbit using a
procedure approved by the institutional ethics committee on animal experimentation. The erythrocytes
were washed three times in PBS (pH 7.4). Finally, erythrocytes were suspended in PBS at a cell density
of 8 × 109 cells/mL.
To determine the hemolytic activity of the catanionic mixtures prepared in this work, we adapted
the procedure described by Pape et al. [27]. A series of different volumes of a concentrated sample,
ranging from 10 to 80 µL, were placed in small Eppendorf tubes containing 25 µL of erythrocyte
suspension and PBS was added to each tube to a total volume of 1 mL. Samples were shaken for 10 min
at room temperature and the tubes were then centrifuged (5 min at 10,000 rpm). The percentage of
hemolysis was determined by comparing the absorbance (540 nm) of the supernatant of the samples
with that of the control totally hemolysed with distilled water. Concentration–response curves were
determined from the hemolysis results and used to calculate the concentration inducing 50% hemolysis
(HC50).
2.10. Ethidium Bromide Fluorescence
The fluorescence spectra of ethidium bromide (EB) (3 mL, 0.16 µM) (Sigma-aldrich, San Luis, MO,
USA) were determined with a PTI Fluorescence Master System fluorescence spectrophotometer
(Horiba, Kyoto, Japan). The excitation wavelength (λexc) was 490 nm and the emission range
530–700 nm. 2 µg of DNA from salmon (average MW 1.3 × 106 ca. 2000 base pairs) was then
added to 3 mL of EB solution and fluorescence spectra were recorded again under the same conditions.
Increasing volumes of pure surfactants or catanionic mixtures were then incorporated to the EB/DNA
solution and fluorescence spectra were recorded after each addition. The EB release from the DNA/EB






here I0 and IEB are the maximum fluorescence intensities obtained for the EB and EB/DNA solutions
and I is the highest fluorescence intensity achieved with different catanionic mixture concentrations.
3. Results and Discussion
3.1. Critical Aggregation Concentration
In this work we used 2 cationic amino acid-based surfactants and 3 anionic surfactants (Figure 1)
to prepare a range of catanionic mixtures at room temperature. The surfactant mixtures contained
different proportions of: (a) LAM and sodium myristate, both with a single chain (LM), (b) double-chain
cationic gemini C3(CA)2 and single-chain anionic sodium laurate (C3L) and (c) C3(CA)2 and anionic
8 S-H, both with a double chain (C3S) (Figure 2). Spontaneous vesicle formation by binary mixtures of
oppositely charged surfactants depends on both the composition of the formulation and the surfactant
structure. Usually a single phase of catanionic vesicles is formed in the diluted cation- or anion-rich
region of the surfactant [28]. Thus, in this work each mixture was prepared in 3 different proportions:
one rich in the cationic surfactant, one rich in the anionic surfactant, and an equimolecular formulation.
Each system was prepared at two different total concentrations (1 and 5 mM).
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Figure 2. Ion pairs types in the prepared binary mixtures. (a) pseudo-dialkyl surfactants in LM systems
(b) pseudo-trialkyl and tetraalkyl surfactants in C3L mixtures and (c) pseudo-tetraalkyl and hexaalkyl
surfactants in C3S systems.
The critical aggregation concentration (cac) of catanionic systems and the critical micellar
aggregation (cmc) of the pure surfactants were determined by fluorescence and conductivity. In general,
cac corresponds to a more generic concept than cmc, it is used when the aggregates in equilibrium
with the monomers are not micelles.
Fluorescence spectra of pyrene in different concentrations of surfactant solutions are shown
in Figure 3. For all systems, the II/IIII ratio decreased as the surfactant concentration increased.
At low surfactant concentration, the II/IIII ratio remained constant at about 1.6, indicating that the
probe was located in a hydrophilic environment. At higher concentrations, the ratio decreased
drastically, in response to the hydrophobic domains of micelles or other aggregates being formed by
the surfactant molecules. The cac or cmc can be obtained from the intersection of these two sections in
the curves (Table 2). Conductivity measurements of LAM and LM mixtures are shown in Figure 3a,
the conductivity values increased linearly with the surfactant concentration until reaching a breakpoint
corresponding to the cmc or cac (Table 2). At higher concentrations, further conductivity increases
were more gradual. Below the cmc, the conductivity is due to both free counterions and charged
surfactant monomers. Above the cmc, the effective micelle charge is reduced due to the binding of
some counterions to the micelle surface. Moreover, the ionic mobility of micelles is lower than that
of monomers.
The cmc values of the pure surfactants were found to be in good agreement with the literature
values [25,29]. Due to their more hydrophobic character, the cmc of the cationic gemini surfactant
C3(CA)2 and the double chain surfactant 8-SH was lower than that of LAM and sodium laurate.
The cac values of the mixed surfactant systems were lower than the cmc of individual cationic
and anionic surfactants, likely due to the synergistic effects of strong electrostatic interactions and
the formation of large aggregates such as vesicles [30,31]. The spontaneous formation of vesicles
requires an optimum value of the packing parameter P, which is defined by three geometric structural
parameters [32]: P = V/lca0, where V is the volume of the hydrophobic portion, lc is the length of
the hydrophobic group, and a0 is the head group area of the surfactants. Micelles are formed when
the P value is less than 12 , whereas higher values promote the formation of vesicles and lamellar
phases. When two oppositely charged single-chain surfactants are mixed, the head groups interact
electrostatically to behave as a single ion pair, which acts as a pseudo double-tailed zwitterionic
surfactant. These strong electrostatic interactions reduce the effective head group area of the catanionic
ion pair and increase the area of the hydrophobic group per molecule relative to that of each
single-chain surfactant. As a result, the P value is close to 1, which favors the formation of vesicles at
very low concentrations.
For the catanionic mixtures prepared with single-chain surfactants (LM), the cac decreased from 4.7
and 1.6 mM for the pure compounds to 0.3 and 0.4 mM for 8.2LM and 2.8LM, respectively. The 5.5LM
mixture precipitated at an equimolar concentration, a frequent occurrence in equimolecular mixtures
of oppositely charged surfactants due to the complete neutralization of ionic charges [15]. The decrease
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in cac was higher for the C3L mixtures, dropping from 3 and 9 mM for the pure compounds to 0.08–0.3
for the catanionic mixtures, and even more so for the C3S mixtures. This behavior can be ascribed to the
different catanionic ion pairs formed in each mixture (Figure 2). In the case of LM, the ion pairs contain
only two alkyl chains. In contrast, the C3L mixtures allow the formation of pseudo surfactants of 3 and
4 hydrophobic chains, as cationic gemini surfactants contain two alkyl chains and two positive charges
(Figure 2), and the C3S mixtures result in pseudo surfactants with four or six alkyl chains. These types
of ion pairs could explain the low cac values obtained for these systems. It was also observed that
the cac values of C3L and C3S increased with the proportion of C3(CA)2. As the cationic surfactants
have two cationic charges and the anionic only one, 8.2C3L contained 14 free cationic charges for
every 16, and 2.8C3L had 4 free anionic charges for every 8. The anion-rich system, being less ionic,
therefore has lower cac values. This would also explain the absence of precipitation in the 5.5 samples,
as neutralization would occur at a 2/1 ratio.
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The cmc values of the pure surfactants were found to be in good agreement with the literature 
values [25,29]. Due to their more hydrophobic character, the cmc of the cationic gemini surfactant 
C3(CA)2 and the double chain surfactant 8-SH was lower than that of LAM and sodium laurate.  
The cac values of the mixed surfactant systems were lower than the cmc of individual cationic 
and anionic surfactants, likely due to the synergistic effects of strong electrostatic interactions and 
the formation of large aggregates such as vesicles [30,31]. The spontaneous formation of vesicles 
requires an optimum value of the packing parameter P, which is defined by three geometric 
structural parameters [32]: P = V/lca0, where V is the volume of the hydrophobic portion, lc is the 
length of the hydrophobic group, and a0 is the head group area of the surfactants. Micelles are 
formed when the P value is less than ½, whereas higher values promote the formation of vesicles 
and lamellar phases. When two oppositely charged single-chain surfactants are mixed, the head 
groups interact electrostatically to behave as a single ion pair, which acts as a pseudo double-tailed 
zwitterionic surfactant. These strong electrostatic interactions reduce the effective head group area 
 


































































































Figure 3. (a) Conductivity against concentration for LAM and LM mixtures, (b) Fluorescence
measurements of LAM and LM mixtures, (c) Fluorescence measureme ts of C3(CA)2, sodium laurate
and their corresponding catanionic mixtures, and (d) Fluorescence spectra against concentration for
C3(CA)2, 8-SH and their catanionic mixtures.
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Table 2. Critical aggregation concentration (cac) of pure surfactants and their catanionic mixtures.
Single Chain Surfactants Double Chain Surfactants
System cac (mM) Fluorescente cac (mM) Conductivity System cac (mM) Fluorescence
LAM 4.7 6.2 C3(CA)2 3.2
Sodium myristate 1.6 - 8-SH 2.5
8.2 LM 0.3 0.45 Sodium laurate 9.1






The cac was also determined by conductivity measurements [33]. Using this technique, it was
only possible to determine the cmc of LAM and the cac of the LM mixtures (Figure 3a) and the values
were slightly lower than those obtained by fluorescence (Table 2). For the gemini mixtures, there was
not an obvious inflection point in the conductivity curves, probably due to the low cmc values and low
counterion binding in catanionic mixtures, where a significant part of the counterion binding role is
already assumed by the minority surfactant in the mixture.
The behavior of the new compounds in aqueous solution was also studied by 1HNMR (Figure 4).
1HNMR spectra were recorded using a Varian 400 MHz to monitor self-aggregation of pure surfactants
as well as their mixtures. In the 1HNMR spectra of pure LAM and sodium myristate (Figure 4a),
the stereochemical splitting resonance corresponding to the different CH2 and CH3 groups of the
molecule is clearly resolved, and the typical Lorentzian-shaped spectra corresponding to the presence of
classical micelles can be observed. The 1HNMR spectra of the catanionic mixtures showed considerable
signal-broadening, which may be associated with the slow motion of the surfactants due to the
formation of large, stable aggregates [34,35]. The 1HNMR spectra also indicated the formation
of catanionic vesicles. Similar behavior was observed for the C3S (Figure 4b) and C3L mixtures
(figures not shown).
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Figure 4. 1HNMR spectra of (a) LAM 6 m (4), Myristate 3 Mm (3), 2.8LM 1 mM (2) and 8.2LM 1 m
(1) (b) C3S ixt res (1 3( )2 5 , 2 8.2 C3S 1 mM, 3 5.5 C3S 1 mM, 4 2.8 C3S 1 mM, 5 8-SH 5 mM).
3.2. Size Distribution and ς-Potential
The cac values as well as the NMR measurements of the binary mixtures suggested the spontaneous
formation of catanionic vesicles. To confirm their formation, the nature of the aggregates was studied.
The hydrodynamic diameters as well as the size distribution of the aggregates were determined by
dynamic light scattering (DLS) studies (Figure 5, Tables 3 and 4). The solution appearance was also
analysed, as a change in the turbidity of a surfactant solution can indicate alterations in the amount
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and/or size of the aggregates. Table 3 summarizes the hydrodynamic diameters and the polydispersity
index (PdI) obtained from the DLS measurements at day 0. The table also shows the visual appearance
of every formulation.
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Figure 5. Size distribution (diameter Dh) for the binary mixtures of (a) LM (b) C3L 1 mM day 0 and day
20 (c) C3L 5 mM day 0 and day 20, (d) C3S 1 mM day 0 and day 20, and (e) C3S 5 mM day 0 and day 20.
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Table 3. Mean diameter, polydispersity index (PdI), ς-potential values, and visual appearance of
the catanionic mixtures at day 0. Photograph of the LM mixtures, left 8.2LM and right 2.8LM.
Photographs corresponding to the C3L and C3S systems: left 2.8, center 5.5, and right 8.2.
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2.8 C3S 242 0.390 −17 
 
5.5 C3S 463 0.343 17 
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20% 
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5.5C3L 191 0.179 24 
8.2C3L 207 0.335 29 
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The DLS results corresponding to the LM mixtures indicate that catanionic vesicles were 
spontaneously formed after mixing the two monocatenary surfactant aqueous solutions in a ratio of 
8/2 and 2/8. The PdI values indicate that both 8.2LM and 2.8LM contained a monodisperse 
population of small vesicles with a mean Dh of 121 nm and 190 nm, respectively. The DLS results 
were supported by visual observations, as the 8.2LM and 2.8LM dispersions were bluish in color, 
which is typical of catanionic vesicles sized in the visible wavelength range (Table 3, Figure 5a) [25]. 
At an equimolar ratio, the mixed solution became very turbid and the surfactant mixture was prone 
to precipitate. When all positive charges are neutralized by the negative ones, the hydrophobic 
content of the system is very high, leading to phase separation. Precipitation when the surfactant 
5.5 LM Precipitation
8.2 LM 121 0.198 +64.7
2.8 C3S 138 0.109 −33.4
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The DLS results corresponding to the LM mixtures indicate that catanionic vesicles were 
spontaneously formed after mixing the two monocatenary surfactant aqueous solutions in a ratio of 
8/2 and 2/8. The PdI values indicate that both 8.2LM and 2.8LM contained a monodisperse 
population of small vesicles with a mean Dh of 121 nm and 190 nm, respectively. The DLS results 
were supported by visual observations, as the 8.2LM and 2.8LM dispersions were bluish in color, 
which is typical of catanionic vesicles sized in the visible wavelength range (Table 3, Figure 5a) [25]. 
At an equimolar ratio, the mixed solution became very turbid and the surfactant mixture was prone 
to precipitate. When all positive charges are neutralized by the negative ones, the hydrophobic 
content of the system is very high, leading to phase separation. Precipitation when the surfactant 
5.5 C3S 212 0.180 +15.3
8.2 C3S 183 0.090 +40.4
2.8C3L 581 0.133 −5.4
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s o ta eo sl  for e  after ixi  t e t o o ocate ar  s rfacta t a eo s sol tio s i  a ratio of 
8/2 a  2/8. e I al es i icate t at bot  8.2  a  2.8  co tai e  a o o is erse 
o latio  of s all esicles it  a ea  h of 121  a  190 , res ecti el . e S res lts 
ere s orte  b  is al obser atio s, as t e 8.2  a  2.8  is ersio s ere bl is  i  color, 
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co te t of t e s ste  is er  i , lea i  to ase se aratio . reci itatio  e  t e s rfacta t 
5.5C3L 924 0.360 +27.3
8.2C3L 572 0.320 +37.4
5 mM
2.8 C3S 217 0.223 −52.5
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The DLS results corresponding to he LM mixtur s indicate that c a i nic v sicles were
spontaneously formed after mixing the two monocate ary surfactant aqueo s solutio s in a ratio of
8/2 and 2/8. The PdI valu s indicate that b th 8.2LM and 2.8LM contained a monodisperse population
of small vesicles with a mean Dh of 121 nm a d 190 nm, resp ctively. Th DLS r sults were supported
by visual observations, as the 8.2LM and 2.8LM dispersions were bluish in color, which is typical of
catanionic vesi les sized in th visible wavelength range (T ble 3, Figure 5a) [25]. At an equimolar ratio,
the mixed solution became very turbid and the surfactant mixture was prone to precipitate. When all
positive charges are neutralized by the negative ones, the hydrophobic content of the system is very
high, leading to phase separation. Precipitation when the surfactant ratio nears equimolarity has been
observed for several catanionic mixtures [15] and is attributed to the formation of zwitterionic ion pairs
without a positive or negative net charge.
Table 3 also contains the values of the ς-potential, a parameter commonly used to assess the
stability of catanionic vesicles under storage [36]. The aggregates tend to repel each other if they have
large positive or negative ς-potential values (+30 mV or −30 mV), otherwise the mixtures start to
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flocculate and precipitate. The storage stability also depends on the size distribution and is generally
improved by high attractive inter-particle interactions (average particle diameter < 500 nm), a PdI < 0.4.
The 8.2 and 2.8 LM formulations exhibited large ς-potential values (−65 and 64 mV) and a small
average diameter, although phase separation occurred in both formulations after 72 h.
In all the mixtures of the gemini surfactant C3(CA)2 with 8-SH (C3S formulations), the translucent
bluish color observed with the naked eye also indicated the spontaneous assembly of aggregates
with sizes comparable to the wavelength of light, such as catanionic vesicles (Table 3). For these
systems, small vesicles with a mean diameter of 138–183 nm were observed and the PdI was below 0.3,
indicating a narrow vesicle size range [37] (Figure 5d). The ς-potential depends on the cationic/anionic
ratio of the mixtures: those that were cation-rich gave a large positive value of +40.4 mV and when
anion-rich, a large negative value. The equimolecular mixture also showed a positive value (+15.3 mV);
as the gemini cationic surfactant possesses two positive charges, at this ratio only half of the cationic
charges are neutralized by the anionic surfactant. There was a clear correlation between the excess
charges and the ς-potential of the mixtures: for every 10 molecules, the 2.8 mixture had 4 negative net
charges, the equimolecular mixture 5 positive charges and the 8.2 mixture 14 positive charges. The size
distribution and ς-potential values suggest a very good and durable stability. Accordingly, visual
inspection of the formulation after 20 days indicated no phase separation and the DLS measurements
showed only a small increase in the mean diameter of the aggregates, the PdI remaining similar. The size
distribution and stability of the three C3S mixtures were also measured at a higher concentration (5 mM).
A less transparent bluish solution was observed, attributable to a higher aggregate concentration, as the
values of the other parameters (Dh, PdI, and ς-potential) were largely unchanged. After 20 days, these
mixtures remained stable, with only a slight increase in size and polydispersity (Figure 5e, Table S1).
Mixing the gemini surfactant C3(CA)2 with sodium laurate (C3L formulations) yielded mostly
milky solutions with large aggregates, with a Dh of around 500 nm for the 8.2 and 2.8 formulations
and 900 for the equimolecular mixture (Figure 5b,c, Table 3). The aggregates were found to have
a higher particle size and PdI compared to the C3S vesicles. As expected, the ς-potential of the
cation-rich and equimolecular mixtures was positive and negative, respectively, for the anion-rich
mixture. However, the anionic C3L vesicles had a lower anionic charge compared to those of the C3S
formulations. The high ratio of sodium laurate decreased the ς-potential values but to a lesser extent
than 8-SH. Being a stronger base than 8-SH, this anionic surfactant is less negatively charged and its
interactions with the gemini surfactant gave rise to large, more insoluble aggregates. This result could
be ascribed to the pH sensitivity of sodium laurate, which has a pKa of 5.4, close to the pH of pure water,
and was therefore likely to be present in the formulations in ionized and neutral forms. The presence
of non-ionized sodium laurate molecules could also explain the large size of the aggregates, given
the absence of attractive electrostatic interaction between these species and the cationic molecules.
At 5 mM, the 5.5C3L and 8.2C3L mixtures did not show the typical appearance of catanionic mixtures,
the viscosity of the solutions suggesting the presence of different aggregates (Table 3). The C3L mixtures
were poorly stable under storage and most of them suffered phase separation after 2 weeks (Table S1).
In general, these formulations exhibited weak intra-particle interactions (related to the large size) and
weak repulsive inter-particle interaction (related to their small ς-potential), which leads to low stability.
Similar results were found by Want el al., who studied mixtures of a bis-quaternary ammonium
surfactant with different anionic amphiphiles. For bisQuat/sodium laurate, phase separation occurred
over a wide range of mixing ratios, while the mixtures with sodium lauroyl sulphate did not precipitate
in any of the formulations studied [38].
It has been reported that the introduction of additives such as cholesterol or alcohols into
vesicular bilayers can modify their physico-chemical and biological properties [39,40]. For example,
cholesterol can influence membrane permeability. This hydrophobic molecule can eliminate the
gel/liquid crystalline phase transition of lipid bilayers, inducing an ordering effect at temperatures
above the Tm (phase transition temperature) and a disordering effect at temperatures below the Tm [41].
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Taking into account these considerations, we decided to investigate how the incorporation of
cholesterol in the catanionic mixtures would affect their physico-chemical and biological properties.
Table 4 shows the Dh, PdI, ς-potential and visual appearance of C3S and C3L (1 mM) prepared with
10% or 20% cholesterol. The addition of 10% cholesterol to C3S solutions did not alter their visual
appearance, which remained bluish. The DLS measurements showed that this additive generally
promoted the formation of mixtures with a single population of larger vesicles (mean Dh 118–463 nm)
and higher polydispersity (PdI 0.225–0.390). The ς-potential values of the cationic systems were largely
unchanged, while the anionic aggregates exhibited lower values. A similar effect was produced by
20% cholesterol: the C3S mixtures maintained good stability, with no phase separation observed in any
sample after 30 days, and the size and polydispersity values remained similar (Table S2).
In the C3L mixtures, the addition of cholesterol at both 10% and 20% had a strong influence on
vesicular size, the mean Dh values being generally lower than for formulations without the additive
(Table 4). Moreover, larger ς-potential values were obtained for the anionic mixtures. The most notable
difference produced by cholesterol in these formulations was in their storage stability. After 30 days the
visual appearance was maintained, and no phase separation was observed (Table S2). The DLS values
after 7 and 30 days showed that the mean Dh and polydispersity were largely unchanged. The improved
stability of these mixtures, compared with solutions without cholesterol, can be ascribed to their lower
aggregate size and higher ς-potential values. A previous study also found that cholesterol enhanced
the physical stability of catanionic vesicles prepared with mixtures of monocatenary and dicatenary
ammonium-based surfactants and sodium dodecyl sulphate [42]. Once incorporated into the vesicular
bilayers, the cholesterol sterol ring tends to maximize contact with neighboring hydrocarbon chains,
thus improving the bilayer mechanical strength. Moreover, by increasing the distance between the
charged head groups in the vesicles, the addition of cholesterol would reduce counterion binding and
consequently increase the ionic strength of the vesicles.
3.3. Antimicrobial Activity
In the last ten years antibiotic resistance has grown to alarming levels [43] due to the abuse or
misuse of antibiotics [44]. While antibiotic resistance is difficult and perhaps impossible to overcome,
the development of new biocompatible antimicrobial systems with novel mechanisms of action can be
an interesting strategy to minimize its emergence.
In this study, we investigated the antimicrobial activity of novel catanionic mixtures composed
of biodegradable surfactants. The cationic surfactant C3(CA)2 was selected for its antimicrobial
properties, its specific spectrum of action and its mechanism of interaction with bacteria [45].
Moreover, previous studies indicate that the gemini C3(CA)2 exhibits higher antimicrobial activity than
the monocatenary LAM. On the other hand, lipoamino acids are also particularly attractive as antiviral
agents and certain acyl amino acid derivatives have been found to inhibit influenza neuraminidase [46].
The antimicrobial activity of the catanionic vesicle dispersions was evaluated against a panel
of clinically relevant microorganisms by determining the minimum inhibitory concentration (MIC)
and the minimum bactericidal concentration (MBC). The MIC and MBC values corresponding to the
catanionic mixtures and their individual components are shown in Figure 6 and Tables S3–S8.
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Fig re 6. I (µ ) f re surfactants as well as their catanionic mixtures without and with (10%)
cholesterol against Gram-positive and Gram-negative bacteria: (a) C3S mixtures against Gram-positive
bacteria (b) C3S mixtures against Gram-negative bacteria, (c) C3L mixtures against Gram-positive
bacteria, (d) C3L mixtures against Gram-negative bacteria, (e) C3L(10%) mixtures against Gram-positive
bacteria, (f) C3L mixtures against Gram-negative bacteria, (g) C3S (10%) mixtures against Gram-positive
bacteria and (h) C3S (10%) mixtures against Gram-negative bacteria MRSA  B. subtilis  K. rhizophila
 S. epidermidis  K. pneumoniae  P. aeruginosa  E. coli  C. albicans. Arrows indicates that the highest
concentration tested did not inhibit the growth of the microorganism.
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While the cationic gemini surfactant exhibited good antimicrobial activity against the three types of
microorganisms tested, the anionic surfactants did not affect their growth. As the bacterial cytoplasmic
membrane carries a net negative charge, a positive charge and suitable hydrophobic/hydrophilic
character is essential for the antimicrobial potential of surfactants [47,48]. The activity of C3(CA)2 was
similar against the three Gram-positive bacteria (MIC values of 9 µM), being slightly lower against
the Gram-negative P. aeruginosa and E. coli (MIC 36 µM), and without any effect on K. pneumoniae at
the highest concentration tested. The tolerance of Gram-negative bacteria to cationic amphiphiles is
well known, being due to the intrinsic permeability barrier of the outer membrane and the role of
lipopolysaccharides [49].
In general, the antimicrobial activity of the pure C3(CA)2 was moderately higher compared to
the catanionic mixtures, although the latter were still very effective. This behavior could be ascribed
to the aggregate morphology of the systems as well as to the cationic charge density. A pure gemini
surfactant tends to form spherical micelles, whereas catanionic mixtures contain large aggregates.
Additionally, all cationic charges in pure systems are free, but in the mixtures, some are neutralized
by the anionic surfactant. It has been reported that the self-assembly properties (aggregate size,
morphology and stability) affect the antimicrobial activity of surfactant systems [50], after electrostatic
targeting the bacterial surface, small aggregates can easily insert into and disrupt the lipidic bacterial
membrane via hydrophobic interactions [51,52].
Our results demonstrate that the surfactant antimicrobial activity mainly depends on the
anionic/cationic ratio. The effectivity of the 8.2 cationic/anionic systems was similar to that of
pure C3(CA)2, decreasing with the proportion of the cationic surfactant. Changes in the surfactant ratio
altered the most important factors affecting the antimicrobial activity: the hydrophobicity and cationic
density of the colloidal systems. The outermost surface of the bacterial cytoplasmic membrane carries
a net negative charge, which leads to a high binding affinity with catanionic vesicles with large positive
ς-potential values. This phenomenon was clearly observed in the 2.8 formulations, whose negative
ς-potential values led to a drastically reduced antimicrobial activity.
C3L formulations were the most active against bacteria and yeast. For example, 2.8C3L was
effective against almost all the tested microorganisms, whereas 2.8C3S showed no activity against
any of them. This difference in performance can be ascribed to the structural stability and dynamics
of the aggregates. The efficient interaction of surfactant monomers with antibacterial membranes is
favored when the molecular aggregates are relatively unstable and easily disassemble into monomers.
The physico-chemical studies of these systems indicate that more weakly interaction occurred between
C3(CA)2 and sodium laurate due to the pH-sensitive behavior of this anionic surfactant. It can then be
assumed that the ion pair formed in the C3L mixtures was more readily separated. Recent reports
indicate that cellular internalization is strongly dependent on aggregate stability; the more stable
aggregates enter cells by endocytosis, disassembling inside, whereas aggregates that can easily
dissociate intercalate into the membranes as monomers, penetrating cells directly [53,54].
Interestingly, the pure C3CA2 did not suppress growth of K. pneumoniae, unlike the C3L mixtures.
It is also remarkable that all catanionic formulations were effective against MRSA. The WHO, based on
various criteria, has created a global priority list of antibiotic-resistant pathogens. The situation is
particularly critical for infections associated with hospitalization, which are mainly caused by the
Gram-negative K. pneumoniae and P. aeruginosa as well as by the Gram-positive Staphylococcus aureus.
Cationic amphiphiles exert antimicrobial activity mainly by disintegrating bacterial membranes
via electrostatic and hydrophobic interactions. In the case of C3(CA)2, flow cytometry analysis and
electron micrographs indicate that E. coli cells treated with this surfactant are killed by membrane
permeabilization [45]. It is thus expected that the catanionic mixtures share this antibacterial
mode of action. As bacteria find it difficult to circumvent such a nonspecific mode of action as
membrane-disruption, such antimicrobial systems are of great interest for reducing the growth of
bacterial resistance [55,56].
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The incorporation of 10% cholesterol to the catanionic mixtures did not modify their antimicrobial
activity, which also decreased as the anionic surfactant percentage grew (Figure 6, Tables S5 and
S6). Formulations with 20% cholesterol exhibited lower activity, possibly because of an increased
hydrophobicity, due to the highly apolar nature of the additive (Table S6).
The action of an antibacterial agent on a bacterial strain can also be characterized by the minimum
bactericidal concentration (MBC), the dosage at which >99.9% of bacteria are killed. This parameter
was determined for the cholesterol-containing catanionic mixtures (Tables S7 and S8 in SI), and the
MBC/MIC ratio ranged from 1 to 2, indicating a bactericidal effect against the tested strains.
The results suggest that the catanionic vesicles obtained by simply mixing an arginine-based
gemini surfactant with an anionic surfactant retain the antimicrobial activity of the cationic surfactant.
Moreover, the antimicrobial potency of these systems can be easily modulated by changing the anionic
surfactant or the cationic/anionic ratios.
3.4. Antibiofilm Activity
Most bacteria form biofilms when they grow on surfaces. MRSA and P. aeruginosa are currently
two problematic bacteria with the ability to develop robust biofilms that are 10 to 1000 times more
resistant to conventional antimicrobials than planktonic–state bacteria. In this context, it is crucial
that new antimicrobial systems can also disperse bacterial biofilms. Accordingly, pre-established
mature biofilms of MRSA and P. aeruginosa were treated with the novel colloidal formulations and
their eradication was measured by a crystal violet staining assay (Figure 7).
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Figure 7. (a) MRSA biofilm dispersion (%) against concentration (µM) of pure surfactants and
their catanionic mixtures, (b) P. aeruginosa biofilm dispersion (%) against concentration (µM) of pure
surfactants and their catanionic mixtures.
Both C3(CA)2 and the catanionic mixtures had a significant antibiofilm effect against the two
strains tested. Up to 70% of MRSA biofilms were dispersed by C3(CA)2 at 36 µM, and up to 60% by the
C3S mixture at 72 µM. The C3L mixtures were less effective, reducing MRSA biofilms by 50% at 125 µM
and having no dispersal affect below this concentration. While low concentrations (18 µM) of C3(CA)2
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dispersed about 60% of P. aeruginosa biofilms, the C3S mixture performed even better, removing up to
70% at subMIC (36 µM). In accordance with these results, it was recently reported that a biosurfactant
loaded in phosphatidylcholine liposomes showed higher activity against MRSA biofilm than when
free [57].
The antibiofilm activity of these catanionic formulations can be ascribed to both their cationic
character and their alkyl chains. A proposed mechanism for biofilm eradication by cationic amphiphiles
first involves perturbation of the extracellular polymeric substance through electrostatic interactions,
which disperses the biofilm and leads to the death of the exposed planktonic cells [58].
The effects of amino acid-based surfactants on biofilms have been scarcely reported to date,
and to our knowledge, this is the first study on the antibiofilm activity of vesicles prepared with these
surfactants. Tack-seung Kim et al. [59] recently found that lauroyl arginine ethyl ester effectively
removed biofilm from reverse osmosis membranes. In general, cationic surfactants are more efficient
at inhibiting the development of biofilms than dispersing them [57,59]. The efficiency of the studied
catanionic systems in eradicating MRSA biofilms is similar to that reported for quaternary ammonium
surfactants [58]. This good activity and the green chemical procedures used for their preparation make
them attractive alternatives to existing methods of biofilm eradication.
3.5. Hemolytic Activity
Many catanionic mixtures have been designed as drug delivery systems, but their biomedical
application is severely limited by strong cytotoxicity. As it is crucial that antimicrobial formulations
are not toxic for mammalian cells, the toxicity of the novel catanionic mixtures toward human cells
was assessed using erythrocytes, one of the most widely used cell membrane systems to study
surfactant–membrane interactions [27].
The percentage of hemolysis plotted against concentration is shown in Figure 8 and the curves
were used to calculate the HC50 (the concentration that causes 50% hemolysis) (Table 5).
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Figure 8. Hemolysis percentage against surfactant concentration for the C3L (a) and C3S (b) systems
and their cholesterol containing mixtures (c,d).
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Table 5. HC50 values of pure surfactants and their catanionic mixtures.
Pure Compounds HC50 µM
Catanionic
Mixtures HC50 µM 10%Chol Mixtures HC50 µM 20% Chol Mixtures HC50 µM
C3(CA)2 60 ± 3.1 2.8C3S 120 ± 6 2.8C3S (10%) >156 2.8C3S (20%) >156
8-SH 100 ± 4.2 5.5.C3S 160 ± 12 5.5.C3S (10%) >156 5.5.C3S (20%) >156
SL >200 8.2.C3S 79 ± 5 8.2.C3S (10%) 85 ± 5 8.2.C3S (20%) >156
2.8C3L >200 2.8C3L (10%) >156 2.8C3L (20%) >156
5.5.C3L >200 5.5.C3L (10%) >156 5.5.C3L (20%) >156
8.2.C3L 110 ± 11 8.2.C3L (10%) 100 ± 8 8.2.C3L (20%) >156
As shown in Table 5 and Figure 8, sodium laurate did not exhibit hemolytic activity at the highest
concentration tested (200 µM). The cationic C3(CA)2 as well as the anionic 8-SH showed low hemolytic
activity, the latter being less toxic. The low interaction of sodium laurate with the erythrocytes can be
explained by its low hydrophobicity (cmc = 9 mM) and its pH-sensitivity. The gemini C3(CA)2 and
8-SH have similar hydrophobicity, although the higher cationic charge density of the former allowed a
more efficient interaction with the cell membrane. The therapeutic index (TI = HC50/MIC) correlates
the MICs with the HC50 to reveal the selectivity of the mixtures against bacteria. Notably, the MIC
values of C3(CA)2 were generally lower than the HC50 (TI > 1), indicating selective action against the
bacterial membrane (Figure 9, Table S9).Pharmaceutics 2020, 12, x FOR PEER REVIEW 19 of 25 
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The selectivity of C3L cholesterol formulations did not increase. Nevertheless, these mixtures can
still be very useful for certain biomedical applications as the vesicles are cationically charged and have
very little cellular toxicity.
Catanionic vesicles possess a tremendous potential for use in different biomedical applications.
However, these systems are leaky and have safety issues due to their possible cytotoxicity. This work
indicates that the main factors affecting the antimicrobial activity and cytotoxicity of catanionic vesicles
(hydrophobicity, cationic charge, and morphology) can be easily tuned by changing the anionic/cationic
surfactant ratio and the surfactants used, and by adding an appropriate additive. In this regard,
the preparation of catanionic mixtures using a cationic gemini arginine-based surfactant can be a
key design principle to endow antimicrobial systems with lower cytotoxicity while retaining or even
enhancing their efficiency. Additionally, the obtained results could be very useful for the optimization
and development of safe and efficient antimicrobial systems that hamper the emergence of resistance.
This hypothesis is confirmed by previous studies that report good selectivity of catanionic mixtures
prepared with C3(CA)2 and an anionic biosurfactant against Gram-negative and Gram-positive
bacteria [61]. The data obtained here also shed light on the structure–activity relationships underlying
the toxicity of these mixtures, which need to be understood for their transfer from the bench to
the bedside.
3.6. DNA Binding Properties
Catanionic mixtures prepared with biocompatible surfactants could be suitable for the development
of vesicles as DNA carriers. With the aim of exploring the potential of the surfactant mixtures studied in
this work for such applications, their interaction with DNA was preliminarily studied using ethidium
bromide (EB) intercalation experiments.
Figure S1 shows the emission fluorescence spectra of EB with increasing concentrations of cationic
surfactants and their catanionic vesicles. As expected, the intensity of EB fluorescence increased
strongly after the ethidium ion intercalated between the DNA base pairs. The addition of catanionic
mixtures causes a quenching of the fluorescence emission intensity (Figure S1). These results indicate
that catanionic aggregates compacted DNA and EB was gradually released from the EB-DNA complex.
Figure 10 shows the percentage of EB displaced from the EB/DNA complex as a function of
the concentration of pure cationic surfactants or the catanionic mixtures. The pure monocatenary
LAM possesses good DNA binding capacity and positively charged LAM catanionic vesicles also
compacted DNA but with a lower effectivity. Previous studies report that catanionic vesicles prepared
by mixing a monocatenary arginine-based surfactant bearing a C12 alkyl chain with sodium octyl and
cetyl surfactants were also able to compact DNA. [62,63]. The DNA affinity of LAM and the 8.2LM
formulation was similar to that of monocatenary surfactants with long alkyl chains [64,65]. In this
context, it has been reported that arginine-based lipids also exhibit DNA-binding properties through
the hydrogen bonds of the guanidinium group [66].
The percentage of EB displaced by the gemini C3(CA)2 and its catanionic vesicles indicates an
excellent DNA binding capacity. Formulations with the arginine-based gemini surfactant were far
more efficient at compacting the DNA than those prepared with LAM.
The higher DNA affinity shown by the gemini-based systems could be ascribed to two
structural factors: the presence of two cationic charges situated on the protonated guanidine
groups, which improves the electrostatic interactions with the negatively charged phosphate of DNA,
and the existence of two alkyl chains, which increases the hydrophobic character of the formulations,
reducing the amount of cationic surfactant needed to saturate the oligonucleotides [67,68]. These results
are in accordance with those of gemini pyridinium [68] and histidine-based gemini surfactants [69].
Pharmaceutics 2020, 12, 857 20 of 24
Pharmaceutics 2020, 12, x FOR PEER REVIEW 20 of 25 
 
3.6. DNA Binding Properties 
Catanionic mixtures prepared with biocompatible surfactants could be suitable for the 
development of vesicles as DNA carriers. With the aim of exploring the potential of the surfactant 
mixtures studied in this work for such applications, their interaction with DNA was preliminarily 
studied using ethidium bromide (EB) intercalation experiments. 
Figure S1 shows the emission fluorescence spectra of EB with increasing concentrations of 
cationic surfactants and their catanionic vesicles. As expected, the intensity of EB fluorescence 
increased strongly after the ethidium ion intercalated between the DNA base pairs. The addition of 
catanionic mixtures causes a quenching of the fluorescence emission intensity (Figure S1). These 
results indicate that catanionic aggregates compacted DNA and EB was gradually released from the 
EB-DNA complex.  
Figure 10 shows the percentage of EB displaced from the EB/DNA complex as a function of the 
concentration of pure cationic surfactants or the catanionic mixtures. The pure monocatenary LAM 
possesses good DNA binding capacity and positively charged LAM catanionic vesicles also 
compacted DNA but with a lower effectivity. Previous studies report that catanionic vesicles 
prepared by mixing a monocatenary arginine-based surfactant bearing a C12 alkyl chain with 
sodium octyl and cetyl surfactants were also able to compact DNA. [62,63]. The DNA affinity of 
LAM and the 8.2LM formulation was similar to that of monocatenary surfactants with long alkyl 
chains [64,65]. In this context, it has been reported that arginine-based lipids also exhibit 
DNA-binding properties through the hydrogen bonds of the guanidinium group [66]. 
 
Figure 10. Release of ethidium bromide (EB) (%) from the EB/DNA complex against concentration of 
cationic surfactants and their catanionic vesicles (μM): C3(CA)2 (■) 8.2 C3L (●), 5.5 C3L (▲) LAM 
(◄), 8.2 LM (►). 
The percentage of EB displaced by the gemini C3(CA)2 and its catanionic vesicles indicates an 
excellent DNA binding capacity. Formulations with the arginine-based gemini surfactant were far 
more efficient at compacting the DNA than those prepared with LAM. 
The higher DNA affinity shown by the gemini-based systems could be ascribed to two 
structural factors: the presence of two cationic charges situated on the protonated guanidine groups, 
which improves the electrostatic interactions with the negatively charged phosphate of DNA, and 
the existence of two alkyl chains, which increases the hydrophobic character of the formulations, 
reducing the amount of cationic surfactant needed to saturate the oligonucleotides [67,68]. These 
results are in accordance with those of gemini pyridinium [68] and histidine-based gemini 
surfactants [69]. 
The DNA affinity of catanionic mixtures was slightly lower than that of the pure surfactants. 
Notwithstanding this, the percentage of EB displaced by these catanionic vesicles from the EB/DNA 
complex indicates an excellent DNA binding capacity. The lower activity of the catanionic 
formulation can be explained by their lower cationic density. 


















Figure 10. Release of ethidium bromide (EB) (%) from the EB/DNA complex against concentration of
cationic surfactants and their catanionic vesicles (µM): C3(CA)2 () 8.2 C3L (•), 5.5 C3L (N) LAM (),
8.2 LM ().
The DNA affinity of catanionic mixtures was slightly lower than that of the pure surfactants.
Notwithstanding this, the percentage of EB displaced by these catanionic vesicles from the EB/DNA
complex i dicates an excellent DNA binding capacity. The lower activity of the catanionic formulation
can be explai ed by their lower cationic density.
The present results indicate a strong interaction between gemini-based catanionic vesicles and
DNA. These results are important from the toxicological point of view, as the catanionic vesicles,
especially the 5.5 formulations, exhibited much less hemolytic activity while retaining almost all
their capacity to compact DNA. This quality endows these systems with an added advantage for
biological applications and suggests that C3L catanionic mixtures are promising candidates for further
investigation in gene delivery.
4. Conclusions
In this work, the physico-chemical and biological properties of catanionic vesicles prepared
with biocompatible surfactants are described in detail. Spontaneously formed vesicles were
obtained by mixing aqueous solutions of cationic arginine-based surfactants with anionic surfactants.
These catanionic mixtur s displ y d a very low critical aggregation conce tration with respect to
the i ividual components, i dicating a strong attra tive interaction between the oppositely charged
amphiphilic molecules, which form highly hydrophobic ion pairs. The mixtures containing cationic
arginine-based surfactants provided excellent monodisperse populations of medium-sized catanionic
vesicles that remained reasonably stable for at least 30 days.
The net surface charge as well as the antimicrobial and hemolytic activity of the vesicles can be
tuned by altering the surfactant mixing ratio, which allows the development of systems with selective
activity against bacteria and without toxicity against red blood cells. Interestingly, the selectivity
and stability of the catanionic vesicles were further improved by the incorporation of cholesterol.
It was also demonstrated that the novel surfactant systems can effectively disperse MRSA and P.
aeruginosa biofilms.
The results of this work indicate that designing catanionic vesicles from biocompatible surfactants
is a useful strategy in the search for selective antimicrobial systems with an optimal balance between
antimicrobial activity and cytotoxicity. The low cytotoxicity and high stability of the vesicles are
also promising features for the development of new drug delivery systems for systemic applications.
Moreover, given their properties, the vesicles could simultaneously act as a vehicle and drug.
Overall, the data obtained provide novel insights into the effect of catanionic vesicles on bacteria and
cellular systems, which could contribute to developing their practical application in biomedical fields.
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at day 20. Photographs corresponding to the C3L and C3S systems: left 2.8, center 5.5, right 8.2, Table S2: Mean
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